Jūratės Digaitienės vaistinė, UAB - financials and debts
Company age: 29 y. 5 mo.
Jūratės Digaitienės vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 118,144 | 103,484 | 153,218 | 139,331 | 146,880 | 145,362 | 168,819 | 159,434 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 13,680 | 6,989 | 23,421 | 10,350 | 11,855 | -233 | 4,893 | 4,464 |
| Equity | 41,238 | 48,227 | 48,118 | 58,468 | 70,323 | 58,490 | 53,582 | 33,296 |
| Liabilities | 14,111 | 10,884 | 16,487 | 10,057 | 15,188 | 20,905 | 16,209 | 22,385 |
| Non-current assets | 1,648 | 799 | 723 | 10,421 | 8,170 | 6,159 | 4,164 | 2,168 |
| Current assets | 53,701 | 58,312 | 63,882 | 58,104 | 77,341 | 73,236 | 65,627 | 53,513 |
| Total assets | 55,349 | 59,111 | 64,605 | 68,525 | 85,511 | 79,395 | 69,791 | 55,681 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,920 | 8,871 | 9,892 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +18.9% | -12.4% | +48.1% | -9.1% | +5.4% | -1.0% | +16.1% | -5.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 24.7% | 11.8% | 36.3% | 15.1% | 13.9% | -0.3% | 7.0% | 8.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 33.2% | 14.5% | 48.7% | 17.7% | 16.9% | -0.4% | 9.1% | 13.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.6% | 6.8% | 15.3% | 7.4% | 8.1% | -0.2% | 2.9% | 2.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.4 | 0.3 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 118,144 | 103,484 | 153,218 | 139,331 | 146,880 | 145,362 | 168,819 | 159,434 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Jūratės Digaitienės vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-13 | 1.22 |
| 2026-08-26 | 2026-09-02 | 1.22 |
| 2026-08-23 | 2026-08-23 | 1.22 |
| 2026-08-19 | 2026-08-19 | 1.22 |
| 2026-07-19 | 2026-08-05 | 1.22 |
| 2026-07-16 | 2026-07-17 | 1.22 |
| 2026-06-16 | 2026-07-06 | 1.22 |
| 2026-05-17 | 2026-06-04 | 1.51 |
| 2026-05-03 | 2026-05-12 | 1.51 |
| 2026-04-24 | 2026-04-29 | 1.51 |
| 2026-01-16 | 2026-01-26 | 485.46 |
| 2026-01-01 | 2026-01-15 | 0.06 |
| 2025-12-16 | 2025-12-30 | 0.06 |
| 2025-11-18 | 2025-12-03 | 0.06 |
| 2025-10-16 | 2025-11-02 | 0.06 |
| 2025-09-16 | 2025-10-06 | 0.16 |
| 2025-08-31 | 2025-09-03 | 0.16 |
| 2025-08-19 | 2025-08-29 | 0.16 |
| 2025-07-16 | 2025-08-06 | 0.16 |
| 2024-06-18 | 2024-07-14 | 0.14 |
| 2024-05-16 | 2024-06-16 | 0.14 |
| 2024-04-16 | 2024-05-14 | 0.14 |
| 2024-03-18 | 2024-04-14 | 0.14 |
| 2024-02-19 | 2024-03-06 | 0.14 |
| 2024-01-16 | 2024-02-11 | 0.14 |
| 2023-12-18 | 2024-01-09 | 0.14 |
| 2023-11-16 | 2023-12-13 | 0.14 |
| 2023-10-24 | 2023-11-09 | 0.14 |
Jūratės Digaitienės vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-01 | 2026-01-05 | 154.44 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Jurates Digaitienes vaistine, UAB is a private limited liability company (code 176623595) operating in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €159.4K, compared with €168.8K in 2024 and €145.4K in 2023. Revenue therefore declined by 5.6% year on year in 2025, but remained above the 2023 level. Net profit was €4.5K in 2025, following €4.9K in 2024 and a small loss of €233 in 2023, indicating a move from break-even to sustained profitability. The 2025 profit margin was 2.8%. At year-end 2025, total assets stood at €55.7K, equity at €33.3K and liabilities at €22.4K. Equity represented 59.8% of assets, while debt-to-equity was 0.67. Asset turnover was 2.86x, ROE was 13.4% and ROA was 8.0%. Revenue per employee was €159.4K and profit per employee was €4.5K.